SpinChip Diagnostics is developing a game changing platform for medical analysis (the SpinChip platform). The SpinChip platform enables earlier diagnosis of serious health conditions by moving diagnostics from centralized laboratories to the point of need. Early knowledge is key to ensure correct patient treatment and improving quality of life. Key to the SpinChip platform is its innovative and effective microfluidic processing system. This technology enables the development of a range of diagnostic tests. SpinChip has already designed, developed, and tested the generic platform with two biochemical assays; high-sensitivity cardiac Troponin I (cTnI) for myocardial infarction, and C-reactive protein (CRP) for inflammatory diseases. The Digital assay development project is of essence to realize the value creation potential of the SpinChip platform by simplifying the process of developing new assays. The project will develop microfluidic models and methods to study the processes taking place within the assay cartridge, where strong centrifugal forces, complex structures, multiphase flows with solids contribute to major R&D challenges. Advanced computer vision- and machine learning algorithms will also be developed for process control, taking advantage of the large amount of image data acquired from each individual test. SINTEF Digital is R&D partner in the project with experience within the relevant fields.
Project leader: Sebastian Stenmark
Institution: SPINCHIP DIAGNOSTICS AS